Rismo, Renathe <br/><br/>
Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease.  [electronic resource] 

 -  Scandinavian journal of gastroenterology  Mar 2013 
 - 311-9 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1502-7708 
<br/><br/><label>Standard No.: </label>10.3109/00365521.2012.758773  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Crohn Disease--drug therapy<br/>Cytokines--genetics<br/>Female<br/>Follow-Up Studies<br/>Gene Expression<br/>Humans<br/>Infliximab<br/>Intestinal Mucosa--metabolism<br/>Male<br/>Middle Aged<br/>RNA, Messenger--metabolism<br/>Recurrence<br/>Remission Induction<br/>Sensitivity and Specificity<br/>Time Factors<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Withholding Treatment<br/>Young Adult